Altimmune
ALT
#6989
Rank
โ‚น50.21 B
Marketcap
โ‚น481.22
Share price
-1.66%
Change (1 day)
-37.07%
Change (1 year)

Revenue for Altimmune (ALT)

Revenue in 2025 (TTM): โ‚น1.72 Million

According to Altimmune's latest financial reports the company's current revenue (TTM ) is โ‚น1.8 Million. In 2024 the company made a revenue of โ‚น1.71 Million a decrease over the revenue in the year 2023 that were of โ‚น35.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Altimmune from 2006 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น1.72 M0.78%
2024 โ‚น1.71 M-95.16%
2023 โ‚น35.46 M-730.25%
2022 -โ‚น5.63 Million-101.71%
2021 โ‚น0.32 B-45.16%
2020 โ‚น0.59 B44.69%
2019 โ‚น0.41 B-67.24%
2018 โ‚น1.26 B47549.81%
2017 โ‚น2.64 M-98.3%
2016 โ‚น0.15 B-78.01%
2015 โ‚น0.70 B9.49%
2014 โ‚น0.64 B-41.64%
2013 โ‚น1.10 B-19.72%
2012 โ‚น1.37 B7.38%
2011 โ‚น1.28 B36.46%
2010 โ‚น0.94 B-26.41%
2009 โ‚น1.27 B-19.19%
2008 โ‚น1.58 B176.99%
2007 โ‚น0.57 B844.79%
2006 โ‚น60.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.36 M 1,030.00%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.86 B 3,210,230.00%๐Ÿ‡บ๐Ÿ‡ธ USA